Infusion Competitors

Pink Sheets . USA . 
Stock . Infusion Brands International
INBI Stock  USD 0.0001  0.00  0.00%   
Infusion Brands Inte competes with LOreal Co, Unilever PLC, Kimberly Clark, Clorox, and Colgate Palmolive; as well as few others. The company conducts business under Consumer Defensive sector and is part of Household & Personal Products industry. Analyzing Infusion Brands competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Infusion Brands to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Infusion Brands Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Infusion Brands competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Infusion Brands' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Infusion Brands. Your research has to be compared to or analyzed against Infusion Brands' peers to derive any actionable benefits. When done correctly, Infusion Brands' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Infusion Brands Inte.

Infusion Brands Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Infusion Brands and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Infusion and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Infusion Brands Inte does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CLX
+ 0.82
UL
CL
+ 0.75
KMB
IPAR
+ 0.74
UL
EL
+ 0.74
CL
EWCZ
+ 0.72
IPAR
HNST
+ 0.71
CL
  
High negative correlations   
EWCZ
- 0.75
KMB
EWCZ
- 0.68
CL
IPAR
- 0.68
KMB
EL
- 0.35
EWCZ
EWCZ
- 0.35
HNST
IPAR
- 0.31
CL

Risk-Adjusted Indicators

There is a big difference between Infusion Pink Sheet performing well and Infusion Brands Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Infusion Brands' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Infusion Brands Competitive Analysis

The better you understand Infusion Brands competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Infusion Brands' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Infusion Brands' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
INBI LRLCY UL KMB CLX CL IPAR HNST EWCZ EL
 0.00 
 0.0001 
Infusion
 0.14 
 94.27 
LOreal
 0.19 
 48.07 
Unilever
 1.28 
 137.78 
Kimberly
 1.24 
 147.78 
Clorox
 0.33 
 88.87 
Colgate
 0.45 
 130.52 
Inter
 1.61 
 3.06 
Honest
 1.70 
 11.59 
European
 1.09 
 147.36 
Estee
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very risky
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Weak
Good
Weak
Good
Very Weak
Insignificant
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Low
Low
Low
Low
Low
Low
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Fairly Valued
Fairly Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Buy
Buy
Hold
Buy
Strong Buy
Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Hold
Strong Buy
Strong Hold
Strong Hold
Hold
Strong Sell
Cautious Hold
Strong Hold
Current Ratio
0.6
0.93
0.8
0.78
0.88
1.17
2.89
3.27
2.57
1.68
Net Asset
10.75 M
43.01 B
75.22 B
17.34 B
5.95 B
16.39 B
1.37 B
201.62 M
735.73 M
23.41 B
Profit Margin
-0.41
0.15
0.11
0.0863
0.0109
0.12
0.12
-0.11
0.0404
0.0308
EBITDA
(4.56 M)
7.88 B
11.54 B
2.34 B
773 M
4.7 B
268.71 M
(18.59 M)
65.03 M
2.66 B
Operating Margin
-0.34
0.19
0.16
0.12
0.16
0.27
0.0574
-0.099
0.23
0.14
Current Valuation
1.18 M
205.86 B
146.53 B
50.98 B
20.95 B
80.98 B
4.4 B
295.27 M
925.06 M
60.09 B
Price To Book
N/A
7.28
6.03
45.62
332.46
115.87
5.79
2.56
6.78
8.71
Retained Earnings
(69.93 M)
15.37 B
47.02 B
8.37 B
583 M
25.29 B
693.85 M
(479.07 M)
(109.51 M)
13.99 B
Current Asset
5.54 M
9.61 B
12.69 B
5.43 B
1.49 B
2.23 B
468.76 M
N/A
N/A
4.22 B
Five Year Return
N/A
1.72
3.36
3.29
2.57
2.36
1.49
N/A
N/A
0.89
Beta
0.55
0.66
0.17
0.41
0.42
0.41
1.16
1.82
1.37
1.07
Number Of Employees
47
87.4 K
128.38 K
41 K
8.7 K
34 K
607
176
120
44.02 K
Shares Outstanding
181.46 M
2.68 B
2.51 B
336.71 M
124.11 M
821.99 M
32.02 M
97.03 M
48.61 M
232.93 M
Cash Flow From Operations
(7.11 M)
6.73 B
9.06 B
3.54 B
1.16 B
3.75 B
105.77 M
19.35 M
55.6 M
1.73 B
Annual Yield
N/A
0.0125
0.0387
0.0378
0.0329
0.0226
0.0229
N/A
N/A
0.0177
Total Debt
N/A
10.7 M
29.6 B
8.11 B
2.92 B
9.06 B
192.37 M
29.87 M
380.39 M
10.17 B
Return On Equity
N/A
0.2
0.34
2.0
0.26
2.79
0.22
-0.29
0.1
0.0727
Z Score
-7.4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.36
0.0948
0.0822
0.1
0.0891
0.15
0.12
-0.1
0.0386
0.0291
Book Value Per Share
-0.27
9.67
7.24
2.72
0.43
0.74
21.85
1.28
1.72
15.94
Number Of Shares Shorted
N/A
N/A
2.05 M
4.41 M
3.55 M
11.75 M
377.46 K
1.15 M
5.5 M
5.23 M
Current Liabilities
9.2 M
9.06 B
20.02 B
6.35 B
1.56 B
2.15 B
131.08 M
N/A
N/A
2.68 B
Total Asset
10.75 M
43.01 B
75.22 B
17.34 B
5.95 B
16.39 B
1.37 B
201.62 M
735.73 M
23.41 B
Debt To Equity
0.05
0.31
1.49
N/A
6.47
N/A
0.22
0.25
2.84
1.21
Target Price
N/A
102.0
46.0
132.75
152.0
91.44
170.6
4.55
18.0
164.5
Last Dividend Paid
N/A
6.0
1.71
4.72
4.78
1.91
2.5
N/A
N/A
2.64
Short Ratio
N/A
N/A
0.82
1.86
2.76
3.08
2.19
0.65
9.06
2.27
Shares Owned By Institutions
N/A
0.49
10.2
78.77
81.26
84.06
57.81
52.01
92.28
91.92
Market Capitalization
1.11 M
226.3 B
120.44 B
45.81 B
18.12 B
72.81 B
4.2 B
301.77 M
717.15 M
53.41 B
Price To Earning
-0.01
47.41
19.48
20.1
45.43
24.43
75.69
N/A
N/A
36.55
Price To Earnings To Growth
N/A
2.34
14.11
1.57
0.43
2.15
2.73
-0.18
0.32
1.6
Price To Sales
0.0766
5.43
2.01
2.04
2.41
3.63
3.07
0.92
3.2
3.28
Net Income
(6.94 M)
4.6 B
6.51 B
1.76 B
161 M
2.3 B
152.65 M
(39.24 M)
8.93 M
1.01 B
Earnings Per Share
-0.17
2.15
2.73
5.21
0.63
2.77
4.75
-0.42
0.17
1.3
Shares Owned By Insiders
N/A
N/A
N/A
0.16
0.1
N/A
43.67
14.92
7.72
0.46
Revenue
18.18 M
32.29 B
59.79 B
20.43 B
7.39 B
19.46 B
1.32 B
344.7 M
221.02 M
15.91 B
Working Capital
(3.67 M)
551 M
(5.61 B)
(1.23 B)
(89 M)
538 M
514.28 M
101.06 M
57.67 M
2.9 B
Cash And Equivalents
294.42 K
2.99 B
4.33 B
427 M
367 M
775 M
195.88 M
66.85 M
31.19 M
4.03 B
Cash Per Share
N/A
1.11
2.58
1.07
2.25
1.27
6.15
0.72
0.79
8.23
Gross Profit
7.34 M
27.68 B
24.17 B
6.22 B
2.9 B
10.25 B
607.42 M
92.31 M
148.12 M
13.43 B
Day Typical Price
1.0E-4
94.13
48.05
136.82
147.02
88.47
130.21
3.09
11.62
147.08
Accumulation Distribution
N/A
0.0111
21512.28
96606.95
25110.9
82533.69
2143.22
18731.52
11605.11
37564.82
Market Facilitation Index
N/A
1.05
N/A
0.0
0.0
N/A
0.0
N/A
0.0
0.0
Daily Balance Of Power
0.0
(0.12)
0.2571
0.4628
0.5355
0.1602
(0.29)
(0.38)
(0.53)
(0.53)
Period Momentum Indicator
N/A
(0.13)
0.09
1.74
1.81
0.29
(0.59)
(0.05)
(0.20)
(1.62)
Rate Of Daily Change
1.0
1.0
1.0
1.01
1.01
1.0
1.0
0.98
0.98
0.99
Day Median Price
1.0E-4
94.07
48.05
136.34
146.64
88.28
130.06
3.11
11.63
146.94
Price Action Indicator
N/A
0.14
0.07
2.31
2.05
0.74
0.17
(0.07)
(0.14)
(0.38)
Coefficient Of Variation
N/A
4383.9
2238.2
738.17
2266.77
490.2
(5,546)
1530.88
(1,136)
876.35
Mean Deviation
N/A
1.11
0.7241
0.8499
0.9952
0.5809
1.38
3.3
2.45
1.84
Jensen Alpha
N/A
0.0337
(0.02)
0.083
(0.01)
0.1
(0.18)
0.0855
(0.50)
0.1787
Total Risk Alpha
N/A
(0.19)
(0.10)
(0.01)
(0.14)
0.0424
(0.29)
(0.38)
(0.79)
(0.07)
Sortino Ratio
N/A
(0.04)
(0.06)
0.0647
(0.03)
0.0869
N/A
0.063
N/A
0.0981
Downside Variance
N/A
2.71
0.6436
1.68
1.42
0.5363
N/A
15.01
N/A
4.14
Standard Deviation
N/A
1.57
0.9878
1.32
1.4
0.7794
1.84
5.2
3.48
2.59
Kurtosis
N/A
5.3
2.26
7.96
3.21
0.6123
1.56
7.86
8.24
5.65
Potential Upside
N/A
2.13
1.59
2.03
2.15
1.38
2.7
7.21
3.42
4.11
Treynor Ratio
N/A
(0.28)
0.054
0.1675
0.0754
0.2597
(0.03)
0.1152
(0.15)
0.2286
Maximum Drawdown
N/A
9.07
5.52
7.67
8.77
4.02
9.15
32.02
24.02
16.61
Variance
N/A
2.48
0.9757
1.75
1.97
0.6074
3.38
27.02
12.12
6.69
Market Risk Adjusted Performance
N/A
(0.27)
0.064
0.1775
0.0854
0.2697
(0.02)
0.1252
(0.14)
0.2386
Risk Adjusted Performance
N/A
0.0203
0.0315
0.0898
0.0331
0.1292
(0)
0.0495
(0.05)
0.0787
Skewness
N/A
(0.39)
0.9024
(0.22)
0.9871
0.0953
(0.90)
2.01
1.79
1.52
Semi Deviation
N/A
1.58
0.7513
1.12
1.13
0.4866
N/A
3.45
N/A
1.83
Information Ratio
N/A
(0.04)
(0.05)
0.0634
(0.02)
0.0817
(0.07)
0.047
(0.12)
0.0772
Value At Risk
N/A
(1.59)
(1.36)
(1.28)
(1.95)
(1.09)
(3.54)
(6.67)
(4.95)
(3.23)
Expected Short fall
N/A
(1.15)
(0.90)
(0.97)
(1.12)
(0.68)
N/A
(4.08)
N/A
(2.06)
Downside Deviation
N/A
1.65
0.8023
1.3
1.19
0.7323
N/A
3.87
N/A
2.04
Semi Variance
N/A
2.51
0.5645
1.25
1.27
0.2368
N/A
11.9
N/A
3.35

Infusion Brands Competition Performance Charts

Five steps to successful analysis of Infusion Brands Competition

Infusion Brands' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Infusion Brands Inte in relation to its competition. Infusion Brands' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Infusion Brands in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Infusion Brands' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Infusion Brands Inte, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Infusion Brands position

In addition to having Infusion Brands in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marketing Thematic Idea Now

Marketing
Marketing Theme
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
View All  Next Launch
Check out Infusion Brands Correlation with its peers.
Note that the Infusion Brands Inte information on this page should be used as a complementary analysis to other Infusion Brands' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Infusion Pink Sheet analysis

When running Infusion Brands' price analysis, check to measure Infusion Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infusion Brands is operating at the current time. Most of Infusion Brands' value examination focuses on studying past and present price action to predict the probability of Infusion Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infusion Brands' price. Additionally, you may evaluate how the addition of Infusion Brands to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Infusion Brands' value and its price as these two are different measures arrived at by different means. Investors typically determine if Infusion Brands is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infusion Brands' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY